#153650

Anti-Growth Differentiation Factor 9B [28A]

Cat. #153650

Anti-Growth Differentiation Factor 9B [28A]

Cat. #: 153650

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Growth Differentiation Factor 9B

Class: Monoclonal

Application: ELISA ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: BioServ UK Ltd

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-Growth Differentiation Factor 9B [28A]
  • Alternate name: Bone morphogenetic protein 15, BMP-15, Growth/differentiation factor 9B, GDF9B
  • Clone: 28A
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 55 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; WB
  • Description: BMP15, also known as GDF9B, plays a crucial role in the regulation of fertility. Clone 28A has been used to detect BMP15 expression and biosynthesis in various carcinoma progression studies.
  • Immunogen: Recognizes sequence SAEVTASSSKHSGPENNQC on the C-terminus of human GDF9B (BMP15)
  • Isotype: IgG1
  • Myeloma used: Sp2/0-Ag14

Target Details

  • Target: Growth Differentiation Factor 9B
  • Molecular weight: 55 kDa
  • Target background: BMP15, also known as GDF9B, plays a crucial role in the regulation of fertility. Clone 28A has been used to detect BMP15 expression and biosynthesis in various carcinoma progression studies.

Applications

  • Application: ELISA ; WB

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Shipping at 4° C

References

  • Bone morphogenetic protein 15 in the pro-mature complex form enhances bovine oocyte developmental competence.
  • Sudiman et al. 2014. PLoS One. 9(7):e103563. PMID: 25058588.
  • Al-Musawi et al. 2013. Endocrinology. 154(2):888-99. PMID: 23284103.
  • Species differences in the expression and activity of bone morphogenetic protein 15.
  • Pulkki et al. 2011. Mol Cell Endocrinol. 332(1-2):106-15. PMID: 20937357.
  • The bioactivity of human bone morphogenetic protein-15 is sensitive to C-terminal modification: characterization of the purified untagged processed mature region.